ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,612.50
0.00%
S&P ASX All Technology
2,939.00
0.00%
Brent Oil
89.635
-0.27%
US Dollar vs AUD
1.56177
0.61%
Bitcoin
63,786.44
0.57%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Eterna Therapeutics Inc (ERNA)

  7. Eterna Therapeutics Inc (ERNA) News

ERNA Eterna Therapeutics Inc

2.16
0.01 (0.47%)
After Hours
Last Updated: 06:28:05
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Eterna Therapeutics Inc ERNA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.01 0.47% 2.16 06:28:05
Open Price Low Price High Price Close Price Previous Close
2.15 2.15 2.16 2.16 2.15
more quote information »

Recent News

Date Time Source Heading
21/2/202400:30GLOBEEterna Therapeutics Announces the Appointment of Peter..
17/2/202409:30EDGAR2Form 3 - Initial statement of beneficial ownership of..
16/2/202423:30EDGAR2Form 8-K - Current report
31/1/202423:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
25/1/202408:15EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
23/1/202416:15EDGAR2Form EFFECT - Notice of Effectiveness
20/1/202408:16EDGAR2Form 8-K - Current report
20/1/202402:31EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
17/1/202408:16EDGAR2Form S-8 - Securities to be offered to employees in employee..
13/1/202408:49EDGAR2Form S-3 - Registration statement under Securities Act of..
04/1/202409:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202409:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202409:01EDGAR2Form 3 - Initial statement of beneficial ownership of..
04/1/202408:15GLOBEEterna Therapeutics Grants New President and CEO Sanjeev..
23/12/202304:05EDGAR2Form SC 13D/A - General statement of acquisition of..
21/12/202308:20EDGAR2Form 8-K - Current report
21/12/202308:15GLOBEEterna Therapeutics Names Sanjeev Luther as President and..
21/12/202307:24EDGAR2Form SC 13G - Statement of acquisition of beneficial..
21/12/202302:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202313:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202310:56GLOBEEterna Therapeutics Announces $9.2 Million Convertible Debt..
15/12/202308:30EDGAR2Form 8-K - Current report
17/11/202308:16EDGAR2Form 8-K - Current report
14/11/202309:30EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/11/202300:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/11/202323:34EDGAR2Form 8-K - Current report
01/11/202323:30GLOBEEterna Therapeutics Appoints James Bristol, Ph.D.,..
06/10/202307:30EDGAR2Form 8-K - Current report
27/9/202306:30EDGAR2Form 8-K/A - Current report: [Amend]
08/9/202320:07EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/9/202307:26EDGAR2Form SC 13D/A - General statement of acquisition of..
06/9/202322:00GLOBEEterna Therapeutics Announces Initiation of Development..
05/9/202322:30GLOBEEterna Therapeutics Appoints Biopharma Industry Veteran..
02/9/202307:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
01/9/202306:15EDGAR2Form 8-K - Current report
29/8/202306:57EDGAR2Form SC 13G - Statement of acquisition of beneficial..
26/8/202309:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/8/202321:00EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
15/8/202306:59EDGAR2Form S-3 - Registration statement under Securities Act of..
12/8/202306:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/8/202307:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202307:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202306:10EDGAR2Form 8-K - Current report
03/8/202307:25EDGAR2Form 8-K - Current report
27/7/202307:05EDGAR2Form SC 13D/A - General statement of acquisition of..
19/7/202306:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/7/202306:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/7/202322:05EDGAR2Form 8-K - Current report
18/7/202322:00GLOBEEterna Therapeutics Announces Completion of $8.7 Million of..
18/7/202320:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Your Recent History

NASDAQ
ERNA
Eterna Therapeutics
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved